Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.
AUTOR(ES)
Yamamoto, J K
RESUMO
More than 90% of cats immunized with inactivated whole infected-cell or cell-free feline immunodeficiency virus (FIV) vaccines were protected against intraperitoneal infection with 10 50% animal infectious doses of either homologous FIV Petaluma (28 of 30 cats) or heterologous FIV Dixon strain (27 of 28 cats). All 15 control cats were readily infected with either strain of FIV. Protection appears to correlate with antiviral envelope antibody levels by a mechanism yet to be determined.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=237403Documentos Relacionados
- Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines.
- Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus
- Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine
- Vaccine Protection against Simian Immunodeficiency Virus by Recombinant Strains of Herpes Simplex Virus
- Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.
